Skip to main content
Equibles
ELUT logo

ELUT · Elutia Inc.

Track ELUT — free

Use ELUT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.82 -0.02 (-2.24%) At close · Sep 4
Rebalance outlook locked
Market Cap
$36.37M
Shares
44.29M

ELUT metrics

65 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.82
Market cap
$36.37M

Price action

19 metrics
Price change (1W)
-6.7%
Price change (30D)
-3.4%
Price change (3M)
-17.8%
Price change (6M)
-24.7%
Price change (YTD)
+18.5%
Price change (1Y)
-59.1%
Trailing year
Price change (5Y)
-90.2%
52-week high
$2.01
52-week low
$0.51
Change from 52-week high
-59.1%
Change from 52-week low
+62.6%
Annualized volatility
77.2%
Beta
0.3
RSI (14D)
39.1
Price vs SMA 50
-10.1%
Price vs SMA 200
-12.8%
Avg volume (3M)
75,555
Relative volume
0.5
Average dollar volume
$71,190

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
44.29M

Valuation

12 metrics
P / E (TTM)
0.8
Trailing earnings · reciprocal yield 121.8%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.0×
reciprocal yield 33.4%
P / book
2.3
reciprocal yield 43.3%
FCF yield
-126.6%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
142.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
57.8%
Operating margin
-214.8%
Trailing 12 months
Net margin
426.9%
Gross profit (TTM)
$7.01M
Operating profit (TTM)
−$26.07M
Net income (TTM)
$51.81M
Trailing 12 months
Diluted EPS (TTM)
$1.00
FCF margin
-379.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-115.47

Growth

11 metrics
Revenue growth YoY
-11.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$12.14M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-4.5%
Year over year · fewer shares
Revenue CAGR (3Y)
-19.8%
Revenue CAGR (5Y)
-22.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
329.0%
Return on assets
118.7%
Debt / equity
—
Current ratio
1.8
EBITDA (TTM)
−$24.37M
Free cash flow (TTM)
−$46.03M
Quick ratio
1.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$19.90M
Total assets
$43.65M
Total debt
$26.10M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$43.99M
Capital expenditures (TTM)
$2.03M
R&D (TTM)
$6.80M
SG&A (TTM)
—
Stock compensation (TTM)
$4.69M
R&D / revenue
56.1%
Stock compensation / revenue
38.6%

Ownership (13F)

3 metrics
13F filers
39
13F filer change QoQ
+4
Institutional ownership
32.6%

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
23 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1708527 CUSIP 05479K106 13F (30d) 30 filings 30 filers Visit website Investor relations